[Form 4] Kindly MD, Inc. Insider Trading Activity
Tyler Matthew Evans, identified as Chief Investment Officer and a director of Kindly MD, Inc. (NAKA), reported on Form 4 that on 08/14/2025 he acquired 2,232,114 shares of the issuer鈥檚 common stock at a reported price of $0, increasing his total beneficial ownership to 2,410,685 shares. The filing is signed on 08/22/2025. The form shows a non-derivative acquisition only and provides no additional explanatory detail about the mechanics or consideration for the transaction.
Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell鈥檈mittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione 猫 firmata in data 22/08/2025. Il modulo indica esclusivamente un鈥檃cquisizione non derivata e non fornisce ulteriori dettagli sulle modalit脿 o sulla controprestazione dell鈥檕perazione.
Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), inform贸 en el Form 4 que el 14/08/2025 补诲辩耻颈谤颈贸 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentaci贸n est谩 firmada el 22/08/2025. El formulario solo muestra una adquisici贸n no derivada y no aporta detalles adicionales sobre la mec谩nica o la contraprestaci贸n de la transacci贸n.
Tyler Matthew Evans電� Kindly MD, Inc.(NAKA)鞚� Chief Investment Officer 瓴� 鞚挫偓搿� 頇曥澑霅橂┌, Form 4鞐� 霐半ゴ氅� 2025-08-14鞐� 氚滍枆須岇偓鞚� 氤错喌欤� 2,232,114欤茧ゼ 氤搓碃霅� 臧�瓴� $0搿� 旆摑頃橃棳 齑� 鞁れ 氤挫湢欤检嫕 靾橂ゼ 2,410,685欤茧 電橂牳鞀惦媹雼�. 頃措嫻 靹滊電� 2025-08-22鞐� 靹滊獏霅橃棃鞀惦媹雼�. 鞏戩嫕鞐愲姅 牍勴寣靸�(non-derivative) 旆摑毵� 旮办灛霅橃柎 鞛堨溂氅� 瓯半灅鞚� 氚╈嫕鞚措倶 雽�臧�鞐� 甏�頃� 於旉皜 靹る獏鞚� 鞐嗢姷雼堧嫟.
Tyler Matthew Evans, identifi茅 comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a d茅clar茅 sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l鈥櫭﹎etteur 脿 un prix d茅clar茅 de 0 $, portant sa d茅tention b茅n茅ficiaire totale 脿 2 410 685 actions. Le document est sign茅 le 22/08/2025. Le formulaire n鈥檌ndique qu鈥檜ne acquisition non d茅riv茅e et ne fournit aucun d茅tail suppl茅mentaire sur les modalit茅s ou la contrepartie de la transaction.
Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enth盲lt keine weiteren erl盲uternden Angaben zu den Modalit盲ten oder der Gegenleistung der Transaktion.
- Insider acquisition disclosed: Reporting person acquired 2,232,114 common shares, increasing transparency about insider ownership.
- None.
Insights
TL;DR: Insider acquired a large block of company stock; filing reports quantity but not economic consideration.
The Form 4 discloses a non-derivative acquisition of 2,232,114 common shares by Tyler Evans, bringing his total to 2,410,685 shares. The transaction date is 08/14/2025 and the report shows a price of $0, with no derivative activity disclosed. From a securities-transaction perspective, the report documents a material shareholding change by a senior officer and director. However, the filing lacks contextual details on how the acquisition was executed or funded, which limits assessment of economic impact.
TL;DR: Officer/director reported sizable share acquisition; the $0 price notation needs clarification in follow-up filings.
As Chief Investment Officer and director, Evans鈥� increased stake to 2,410,685 shares is notable for ownership disclosure and governance transparency. The Form 4 contains the required signature and dates but does not explain the $0 price or indicate a Rule 10b5-1 plan; absence of that detail means investors must rely solely on the disclosed numbers. This filing satisfies the basic Section 16 reporting obligation but invites questions about the transaction鈥檚 nature that are not answered in this record.
Tyler Matthew Evans, indicato come Chief Investment Officer e amministratore di Kindly MD, Inc. (NAKA), ha dichiarato nel Form 4 che il 14/08/2025 ha acquisito 2.232.114 azioni ordinarie dell鈥檈mittente a un prezzo riportato di $0, portando la sua partecipazione beneficiaria totale a 2.410.685 azioni. La comunicazione 猫 firmata in data 22/08/2025. Il modulo indica esclusivamente un鈥檃cquisizione non derivata e non fornisce ulteriori dettagli sulle modalit脿 o sulla controprestazione dell鈥檕perazione.
Tyler Matthew Evans, identificado como Chief Investment Officer y director de Kindly MD, Inc. (NAKA), inform贸 en el Form 4 que el 14/08/2025 补诲辩耻颈谤颈贸 2.232.114 acciones comunes del emisor a un precio declarado de $0, aumentando su propiedad beneficiaria total a 2.410.685 acciones. La presentaci贸n est谩 firmada el 22/08/2025. El formulario solo muestra una adquisici贸n no derivada y no aporta detalles adicionales sobre la mec谩nica o la contraprestaci贸n de la transacci贸n.
Tyler Matthew Evans電� Kindly MD, Inc.(NAKA)鞚� Chief Investment Officer 瓴� 鞚挫偓搿� 頇曥澑霅橂┌, Form 4鞐� 霐半ゴ氅� 2025-08-14鞐� 氚滍枆須岇偓鞚� 氤错喌欤� 2,232,114欤茧ゼ 氤搓碃霅� 臧�瓴� $0搿� 旆摑頃橃棳 齑� 鞁れ 氤挫湢欤检嫕 靾橂ゼ 2,410,685欤茧 電橂牳鞀惦媹雼�. 頃措嫻 靹滊電� 2025-08-22鞐� 靹滊獏霅橃棃鞀惦媹雼�. 鞏戩嫕鞐愲姅 牍勴寣靸�(non-derivative) 旆摑毵� 旮办灛霅橃柎 鞛堨溂氅� 瓯半灅鞚� 氚╈嫕鞚措倶 雽�臧�鞐� 甏�頃� 於旉皜 靹る獏鞚� 鞐嗢姷雼堧嫟.
Tyler Matthew Evans, identifi茅 comme Chief Investment Officer et administrateur de Kindly MD, Inc. (NAKA), a d茅clar茅 sur le Form 4 que le 14/08/2025 il a acquis 2 232 114 actions ordinaires de l鈥櫭﹎etteur 脿 un prix d茅clar茅 de 0 $, portant sa d茅tention b茅n茅ficiaire totale 脿 2 410 685 actions. Le document est sign茅 le 22/08/2025. Le formulaire n鈥檌ndique qu鈥檜ne acquisition non d茅riv茅e et ne fournit aucun d茅tail suppl茅mentaire sur les modalit茅s ou la contrepartie de la transaction.
Tyler Matthew Evans, angegeben als Chief Investment Officer und Direktor von Kindly MD, Inc. (NAKA), meldete im Formular 4, dass er am 14.08.2025 2.232.114 Stammaktien des Emittenten zu einem angegebenen Preis von $0 erworben hat, wodurch sein gesamtes wirtschaftliches Eigentum auf 2.410.685 Aktien anstieg. Die Einreichung ist datiert und unterschrieben am 22.08.2025. Das Formular verzeichnet nur einen nicht-derivativen Erwerb und enth盲lt keine weiteren erl盲uternden Angaben zu den Modalit盲ten oder der Gegenleistung der Transaktion.
FAQ
What did Tyler Matthew Evans report on the Form 4 for NAKA?
What price was reported for the shares acquired in the Form 4 (NAKA)?
What is Tyler Evans鈥� role at Kindly MD, Inc. as shown on the Form 4?
When was the Form 4 signed and filed by the reporting person?
Does the Form 4 report any derivative securities transactions for NAKA?
